Tim Donald Johnson - 10 Nov 2026 Form 4 Insider Report for Health In Tech, Inc. (HIT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
13 Nov 2026, 17:34:57 UTC
Prior SEC filing
19 Oct 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Lori Babcock, as attorney-in-fact for Tim Johnson
Filing notes and source

Key filing fact

Tim Donald Johnson filed Form 4 for Health In Tech, Inc. (HIT) on 13 Nov 2026.

Key facts

  • This page summarizes Tim Donald Johnson's Form 4 filing for Health In Tech, Inc. (HIT).
  • 7 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 13 Nov 2026, 17:34.

Change

  • Previous filing in this sequence was filed on 19 Oct 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001993657 Primary reporting owner

Johnson Tim Donald

Relationship
Executive Chairman, Director, 10%+ Owner
Address
701 S. COLORADO AVE, SUITE 1, STUART
Signature
/s/ Lori Babcock, as attorney-in-fact for Tim Johnson
Signature date
13 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HIT transaction

Class A Common Stock

Award

Transaction value
Shares
+650,000
Change %
+2.8%
Price
$0.000000*
Shares after
23,801,298
Date
10 Nov 2026
Ownership
Direct
Footnotes
F1
HIT transaction

Class A Common Stock

Award

Transaction value
Shares
+800,000
Change %
+3.4%
Price
$0.000000*
Shares after
24,601,298
Date
10 Nov 2026
Ownership
Direct
Footnotes
F2
HIT transaction

Class A Common Stock

Award

Transaction value
Shares
+600,000
Change %
+2.4%
Price
$0.000000*
Shares after
25,201,298
Date
10 Nov 2026
Ownership
Direct
Footnotes
F3
HIT transaction

Class A Common Stock

Award

Transaction value
Shares
+600,000
Change %
+2.4%
Price
$0.000000*
Shares after
25,801,298
Date
10 Nov 2026
Ownership
Direct
Footnotes
F4
HIT transaction

Class A Common Stock

Award

Transaction value
Shares
+200,000
Change %
+0.78%
Price
$0.000000*
Shares after
26,001,298
Date
10 Nov 2026
Ownership
Direct
Footnotes
F5
HIT transaction

Class A Common Stock

Award

Transaction value
Shares
+200,000
Change %
+0.77%
Price
$0.000000*
Shares after
26,201,298
Date
10 Nov 2026
Ownership
Direct
Footnotes
F6, F8
HIT transaction

Class B Common Stock

Award

Transaction value
Shares
+200,000
Change %
+2.2%
Price
$0.000000*
Shares after
9,200,000
Date
10 Nov 2026
Ownership
Direct
Footnotes
F7, F9
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

Represents restricted shares of Class A Common Stock granted under the Health In Tech, Inc. Equity Incentive Plan (the "Plan") pursuant to a Restricted Stock Award Agreement dated as of October 20, 2026. The grant was contingent upon, and the shares were issued upon, stockholder approval of an amendment to the Plan at the Issuer's 2026 Annual Meeting of Stockholders on November 10, 2026. The shares vest in twelve equal monthly installments commencing November 15, 2026, subject to continued service through each vesting date.

Footnote F2

Represents restricted shares of Class A Common Stock that vest in full upon the closing of an acquisition by the Issuer on or before December 31, 2028, subject to continued service through such closing, and are otherwise forfeited without consideration.

Footnote F3

Represents restricted shares of Class A Common Stock that are forfeited without consideration unless the Issuer's market capitalization (measured by 10-day VWAP) exceeds $150 million on or before April 30, 2028 (the "Achievement Date"). Thereafter, the shares vest in twelve equal monthly installments, subject to continued service, commencing on the 15th of the month if the Achievement Date is before the 15th, or otherwise on the 1st of the next month.

Footnote F4

Represents restricted shares of Class A Common Stock that are forfeited without consideration unless the Issuer's market capitalization (measured by 10-day VWAP) exceeds $300 million on or before December 31, 2028 (the "Achievement Date"). Thereafter, the shares vest in twelve equal monthly installments, subject to continued service, commencing on the 15th of the month if the Achievement Date is before the 15th, or otherwise on the 1st of the next month.

Footnote F5

Represents restricted shares of Class A Common Stock that are forfeited without consideration unless the Issuer's market capitalization (measured by 10-day VWAP) exceeds $500 million on or before December 31, 2029 (the "Achievement Date"). Thereafter, the shares vest in twelve equal monthly installments, subject to continued service, commencing on the 15th of the month if the Achievement Date is before the 15th, or otherwise on the 1st of the next month.

Footnote F6

Represents restricted shares of Class A Common Stock that are forfeited without consideration unless the Issuer's market capitalization (measured by 10-day VWAP) exceeds $1 billion on or before December 31, 2031 (the "Achievement Date"). Thereafter, the shares vest in twelve equal monthly installments, subject to continued service, commencing on the 15th of the month if the Achievement Date is before the 15th, or otherwise on the 1st of the next month.

Footnote F7

Represents restricted shares of Class B Common Stock on the terms described in footnote (3).

Footnote F8

Includes 3,663,279 restricted shares of Class A Common Stock and 22,538,019 unrestricted shares of Class A Common Stock. Excludes 200,000 restricted shares of Class B Common Stock, 9,000,000 shares of Class B Common Stock and 734,707 options to purchase shares of Class A Common Stock.

Footnote F9

All unvested restricted shares reported herein vest in full upon a Change in Control (as defined in the Plan).

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .